News

Closing gaps to find new energy sources

Brian Sandalow
By Brian Sandalow
June 15, 2022

There are countless reasons why the need is intensifying for low-cost fuels and chemicals from sustainable resources. Global population is rising, living standards are on an upward trajectory, the market remains highly competitive, and the scarcity of resources is increasingly problematic, just to name a few. 

One potential solution comes from industrial biotechnology’s use of microbial cell factories, which offer advantages with respect to distributed manufacturing and an opportunity for reducing or even capturing greenhouse gas emissions. Yet designing, building, and optimizing biosynthetic pathways in cells remains complex, risky, and time-consuming.

“These factors are exacerbated in industrially relevant, non-model organisms for which genetic tools are not as sophisticated, high-throughput workflows are often lacking, and transformation idiosyncrasies exist,” Northwestern University's Michael Jewett said. “Moreover, most metabolic engineering efforts have chiefly focused on linear heterologous pathways that limit co-development of multiple biochemical products.”  

New work from a multi-institutional team of researchers including Jewett could close some of those gaps. 

Courtesy of Northwestern University
Michael Jewett is a professor and the director of the Center for Synthetic Biology at Northwestern University. His lab studies how complex biological systems are engineered.

Jewett and collaborators from LanzaTech and the University of South Florida optimized and implemented a cyclic reverse beta-oxidation (r-BOX) pathway for the specific production of butanol, butanoic acid, hexanol and hexanoic acid across three biotechnological platforms. The three platforms include a cell-free system, a heterotrophic model organism (E. coli), and an autotrophic organism (C. autoethanogenum) capable of fixing carbon and using synthesis gas — a mixture of carbon monoxide and hydrogen — as the sole carbon and energy source.  

Jewett and his teammates reported their work in the journal Nature Communications. Jewett is the Walter P. Murphy professor of chemical and biological engineering and director of the Center for Synthetic Biology. The other corresponding authors were LanzaTech's vice president for synthetic biology, Michael Köpke, and USF professor Ramon Gonzalez. 

Building off past research published in Nature Biotechnology, where researchers selected, engineered and optimized a bacteria strain and then successfully demonstrated its ability for carbon-negative production of acetone and isopropanol, this investigation streamlines the process and expands the spectrum of molecules that can be produced. A key feature of their work was the creation of an automated liquid-handling workflow based on cell-free biosynthesis, which was then tailored for r-BOX. This allowed the team to rapidly screen 762 unique pathway combinations to identify optimal enzyme sets for enhanced product selectivity in weeks opposed to months. 

“Our work forms a new blueprint for the generation and optimization of biochemical pathways for metabolic engineering and synthetic biology,” Jewett said. “This will facilitate design-build-test cycles of biosynthetic pathways by decreasing the number of the strains that need to be engineered and time required to achieve desired process objectives.” 

Gonzalez  added: “The iterative and modular nature of r-BOX enables the synthesis of products of different chain lengths and functionalities at high carbon and energy efficiency. This allowed us to co-develop tailored processes for four different products, rather than for just for a single product. r-BOX can further be extended to an array of other products of interest building on the developed workflows,” which the authors discussed in a separate article published in the Journal of Industrial Microbiology and Biotechnology.  

The next steps, Köpke said, are scaling up production and expanding the scope of sustainable chemicals made by biology.  

“LanzaTech already operates two commercial facilities that convert industrial off gases into ethanol, mitigating hundreds of thousands of tons greenhouse gas emissions,” Köpke said. “The implementation of r-BOX will increase the flexibility of biological processes to adapt to new markets, expand the range of fossil-derived products that can be displaced with bio-derived alternatives, and enhance the economic benefits for co-produced fuels.” 

This article was republished with permission from Northwestern University’s McCormick School of Engineering. Read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Brian Sandalow
Brian Sandalow

Brian Sandalow is a senior communications coordinator at the Northwestern University McCormick School of Engineering.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

‘Inert’ ingredients in pesticides may be more toxic to bees than scientists thought
News

‘Inert’ ingredients in pesticides may be more toxic to bees than scientists thought

Dec. 9, 2023

Pesticide users sometimes know very little about how inerts function. That’s partly because they are regulated very differently than active ingredients.

FDA approves CRISPR–Cas9 therapy for sickle cell disease
News

FDA approves CRISPR–Cas9 therapy for sickle cell disease

Dec. 8, 2023

The gene editing treatment from Vertex Pharmaceuticals and CRISPR Therapeutics is the first of its kind

From the journals: MCP
Journal News

From the journals: MCP

Dec. 8, 2023

Metals contaminate protein samples. Lipid droplets go haywire in Huntington’s. Nerve cells respond to stimulation. Read about these recent papers.

The perfect storm
Feature

The perfect storm

Dec. 6, 2023

The world has 2023 Nobel laureates Katalin Karikó, Drew Weissman and others to thank for laying a foundation for the COVID-19 vaccine decades before the pandemic.

Throw your hat in the ring!
Annual Meeting

Throw your hat in the ring!

Dec. 6, 2023

Apply to speak at Discover BMB in Chicago in 2025.

How bacteria inhibit gene expression
Journal News

How bacteria inhibit gene expression

Dec. 5, 2023

Researchers show how altering activity of the transcription factor CarD can cause downregulation and upregulation of some genes.